SCHEMBL6989104

SCHEMBL6989104

CC[CH]Oc1c[nH]c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 1/20 0.50
HTR1A P08908 3/20 0.47
HTR6 P50406 2/20 0.47
HTR2A P28223 4/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
GPR84 Q9NQS5 3/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
ATM Q13315 1/20 0.44
AHR P35869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11018667 0.83 MEN1 (0.47) MEN1KMT2ASLC22A6KDM4EALDH1A1
SCHEMBL1198963 0.80 SLC22A6 (0.54) MEN1KMT2ASLC22A6KDM4EALDH1A1
SCHEMBL5229462 0.77 SLC22A6 (0.54) MEN1KMT2ASLC22A6KDM4EMAPT
SCHEMBL71774 0.77 SLC22A6 (0.54) MEN1KMT2ASLC22A6KDM4EALDH1A1
Hydrochloric Acid SCHEMBL29131483 0.74 SLC22A6 (0.51) MEN1KMT2ASLC22A6KDM4EALDH1A1
SCHEMBL1899742 0.74 SLC22A6 (0.59) MEN1KMT2ASLC22A6MAPTGPR84
SCHEMBL6535531 0.73 SLC22A6 (0.58) MEN1KMT2ASLC22A6MAPTHTR1A
SCHEMBL3538344 0.73 SLC22A6 (0.58) MEN1KMT2ASLC22A6MAPTHTR1A
SCHEMBL18932160 0.73 SLC22A6 (0.54) MEN1KMT2ASLC22A6KDM4EALDH1A1
SCHEMBL24316005 0.72 MEN1 (0.53) MEN1KMT2ASLC22A6KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0859004-B1 Piperidine derivatives having anxiolytic effect LUNDBECK & CO AS H (DK) 2003-05-02 EP disclosed
US-6207677-B1 ADMINISERING SIGMA RECEPTOR BINDING PIPERIDINE DERIVATIVE FOR TREATING ANXIETY, EPILEPSY, CONVULSION, MOVEMENT DISORDER, AMNESIA H. LUNDBECK A/S (DK) 2001-03-27 US disclosed
US-6031099-A Piperidine derivates having anxiolytic effect H. LUNDBECK A/S (DK) 2000-02-29 US disclosed
US-5807871-A PSYCHOLOGICAL DISORDERS, ALZHEIMER OR PARKINSON DISEASE H. LUNDBECK A/S (DK) 1998-09-15 US disclosed
EP-0593511-B1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT LUNDBECK & CO AS H (DK) 1998-09-02 EP disclosed
EP-0859004-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-08-19 EP disclosed
EP-0853085-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-07-15 EP disclosed
US-5665725-A Piperidine derivatives having anxiolytic effect Lundbeck, H. (DK) 1997-09-09 US disclosed
EP-0593511-A1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT H. LUNDBECK A/S (DK) 1994-04-27 EP disclosed
WO-1992022554-A1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT H. LUNDBECK A/S (DK) 1992-12-23 WO disclosed
EP-0518805-A1 Piperidine derivatives H. LUNDBECK A/S (DK) 1992-12-16 EP disclosed